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Abstract
Neurologic disease caused by human immunodeficiency virus type 1 (HIV-1) is ultimately refractory to highly active
antiretroviral therapy (HAART) because of failure of complete virus eradication in the central nervous system (CNS), and
disruption of normal neural signaling events by virally induced chronic neuroinflammation. We have previously reported
that HIV-1 Tat can induce mitochondrial hyperpolarization in cortical neurons, thus compromising the ability of the neuron
to buffer calcium and sustain energy production for normal synaptic communication. In this report, we demonstrate that
Tat induces rapid loss of ER calcium mediated by the ryanodine receptor (RyR), followed by the unfolded protein response
(UPR) and pathologic dilatation of the ER in cortical neurons in vitro. RyR antagonism attenuated both Tat-mediated
mitochondrial hyperpolarization and UPR induction. Delivery of Tat to murine CNS in vivo also leads to long-lasting
pathologic ER dilatation and mitochondrial morphologic abnormalities. Finally, we performed ultrastructural studies that
demonstrated mitochondria with abnormal morphology and dilated endoplasmic reticulum (ER) in brain tissue of patients
with HIV-1 inflammation and neurodegeneration. Collectively, these data suggest that abnormal RyR signaling mediates the
neuronal UPR with failure of mitochondrial energy metabolism, and is a critical locus for the neuropathogenesis of HIV-1 in
the CNS.
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Introduction
Infection of the central nervous system (CNS) with the human
immunodeficiency virus type 1 (HIV) occurs rapidly after primary
infection [1]. The phenotype of HIV associated dementia (HAD)
after the introduction of highly active antiretroviral therapy
(HAART) has changed considerably with a more indolent time
course, frequently characterized by waxing and waning neurologic
deficits, suggesting a change in nomenclature to HIV-1 associated
neurologic deficits (HAND) [2]. Alarmingly, more recent studies of
incidence and prevalence of the neurologic component of HIV-1
infection demonstrate that neural injury continues in some patients
regardless of the ability of HAART to achieve virologic
suppression and normalization of immunologic parameters [3].
The CNS can act as a reservoir for HIV as agents that comprise
HAART do not achieve a level of CNS penetration that can fully
eradicate the virus [2,4]. In patients with improved systemic health
from HAART, it is HAART’s failure to control HIV-1’s effects on
the signaling pathways that mediate normal communication
between immune effecting glias and vulnerable neurons, that has
substantially contributed to the rise in HAND prevalence since
2000 [5]. Thus HAND continues to be a problem of pandemic
proportions.
Since HIV-1 only infects CNS cell types that express the
chemokine receptors CD3, CCR5 and/or CXCR4 (i.e. microglia,
perivascular macrophages, and a restricted population of astro-
cytes) [6], structural damage with accompanying neurologic
disease [7] occurs because of pathway activation that leads to
release of inflammatory molecules such as nitric oxide (NO),
tumor necrosis factor alpha (TNF-a), and platelet activating factor
(PAF); changes in ambient recycling of glutamate by astrocytes;
and the release of viral regulatory proteins, such as the trans
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protein gp120 [12]. At the light microscopic level, the neuropa-
thology of HIV-1 infection is notable for changes in the dendritic
arbor with varicosities (‘‘beading’’–13); accumulation of beta
amyloid precursor protein (b-APP) in axons [14]; neuronal
apoptosis [15,16]; and reactive astrocytosis, microgliosis, and
multinucleated giant cells [17]. Surprisingly, ultrastructural
analyses of brain tissue from patients with HIV-1 infection have
focused on changes in endothelial architecture, including thinning
and vacuolization of the basal lamina [18], but no study has
focused on changes in intracellular organelles or synaptic
architecture of neurons.
Of the many HIV-induced neurotoxins, Tat is remarkable
because it is actively released into the extracellular space by infected
microglia, macrophages and astrocytes [10; 19–21]. Unbound Tat
has been detected in the sera of HIV
+ patients, reaching
concentrations as high as 40 ng/mL [22]. It should be noted that
this measurement is probably a gross underestimate of Tat’s local
concentration; Tat in vivo can be sequestered by endogenous
glycosaminoglycans and heparin sulfates effectively lowering the
detectable amounts of Tat circulating unbound. This observation
lends credence to the notion that infiltrating microglia/macrophage
adjacent to a synapse would have greatly increased local
concentrations of Tat. However, once released from a cell Tat
can enter virtually all neural cell types via its arginine-rich basic
domain, termed the protein transduction domain (PTD) [23–26].
Tat can modulate intracellular calcium concentrations through
activation of endoplasmic reticulum (ER) pathways in vulnerable
neurons [26–28]. Protein folding in the ER relies on foldases,
chaperones, and lectins that require high concentrations of
calcium and an oxidized environment in order to perform
properly (Schroder 2005, Wetmore 1996). This in turn raises the
question of whether Tat can overwhelm the protein folding
capacity of the ER and induce the unfolded protein response
(UPR) pathway [29].
Induction of the UPR pathway is designed to reduce net protein
translation and results in the up-regulation of a specific set of genes
that function to relieve this stress. Phosphorylation of the
transmembrane protein kinase–like endoplasmic reticulum kinase
(PERK) is one of the initial events in the UPR pathway and is
responsible for the downstream phosphorylation of eukaryotic
initiation factor 2a (eIF2a) that prevents 80S ribosome assembly,
inhibiting protein translation [30]. Inositol requiring kinase 1
(IRE1) can dimerize in conjunction with PERK phosphorylation
and cleave the mRNA of X-box binding protein 1 (XBP1) to
produce an active 54-kDa transcription factor that is responsible
for maintaining the UPR pathway [31–33]. If the offending ER
toxicant is eliminated, the UPR pathway shuts down and normal
protein translation and folding resumes. Conversely, if the UPR
pathway remains functionally active, the pro-apoptotic protein
CHOP (CCAAT/enhance binding protein (C/EBP) homologous
protein) is up-regulated and the cell undergoes apoptosis [34].
Our laboratory and others have previously described the
phenomenon of mitochondrial hyperpolarization in cortical
neurons after exposure to Tat [35] and other stressors [36–38].
Previously, we demonstrated that application of Tat to cortical
neurons induced a rapid decrease of mitochondrial calcium
leading us to speculate that it was loss of the free calcium cation
from mitochondria that resulted in hyperpolarization of mito-
chondrial membrane potential (DYm) [39]. Due to the importance
of the ER in both calcium signaling and mitochondrial function,
we investigated the effect of HIV-1 Tat on sequestration of
calcium in the ER and demonstrate that HIV-1 Tat induces the
rapid loss in ER calcium through the activation of the ryanodine
receptor (RyR) with initiation of the UPR. We further show that
antagonism of the RyR reversed Tat-induced hyperpolarization of
DYm. In vivo delivery of HIV-1 Tat to murine CNS also results in
pathologic dilation of ER and changes in mitochondrial
morphology. Furthermore, these ultrastructural changes also
occur in neurons of the frontal cortex from patients with HIV-1
encephalitis and dementia. These results suggest a common
mechanism via RyR signaling that rapidly initiates endoplasmic
reticulum and mitochondrial calcium release as part of a
generalized neuronal stress response that appears to have enduring
consequences for the neuropathogenesis of HIV-1.
Results
Acute exposure to Tat induces calcium loss from the ER
via the ryanodine receptor
In our previous studies of cortical neurons exposed to HIV-1
Tat, we concluded that neuronal mitochondria suffered a loss of
energy metabolism reflected by decreased NAD(P)H, as well as
[Ca
+2][39]. Because of the changes in mitochondrial [Ca
+2], we
investigated the ER as a potential locus for these effects. The ER is
responsible for the storage of Ca
2+ and has the ability to induce
rapid efflux of Ca
2+ in response to a variety of cellular signals,
including inositol 1,4,5-triphosphate (IP3) receptors and ryanodine
receptors (RyR) [40]. There are several dyes used to measure
intracellular Ca
2+ concentration; however none are specific to the
ER [41]. Using a ratiometric, ER-targeted calmodulin CFP:EYFP
(cyan fluorescing protein to enhanced yellow fluorescing protein)
construct, we were able to measure ER calcium concentrations in
real time after application of HIV-1 Tat to cortical neurons [42].
Since Tat is known to induce apoptosis in neurons in a dose-
dependent fashion, for all subsequent experiments we used the
lowest sub-lethal concentration of Tat (100 ng/ml=[,8 nM])
that would allow us to reproducibly model neuronal dysfunction,
but not apoptosis [28,35].
Cortical neurons exposed to Tat exhibited a rapid loss of ER
Ca
2+stores as indicated by the loss in CFP:EYFP fluorescence
(Figure 1). FRET imaging has an advantage over traditional
calcium sensitive dyes in that the ratio between the two
fluorophores acts as an internal control and is less susceptible to
fluctuations and photo-bleaching that commonly plague single
wavelength dyes. Exposure to 8 nM Tat elicited an initial loss of
,6% of the fluorescent signal with a continued decrement to
,80% of control fluorescence over a 10 minute period (Figure 1A).
To investigate the mechanism responsible for the release of ER
Ca
2+, we pre-treated cortical neurons for 30 min with 20 mM
ryanodine (Ry), a concentration which inhibits RyR channel
opening (Bardo 2006). Tat-challenged cells showed no loss of ER
CFP:EYFP fluorescence when pre-treated with ryanodine, indi-
cating that ryanodine blocks Tat-induced destabilization of the ER
Ca
2+ pool (Figure 1A).
There are several other mechanisms that can mobilize ER Ca
2+
pools, thus altering [Ca
2+] in this organelle, including IP3-sensitive
stores and the sarco-/endoplasmic reticulum Ca
2+–ATPase
(SERCA) pump [40]. To determine whether either of these
mechanisms was responsible for the observed changes in ER
[Ca
2+], we pretreated cortical neurons for 30 minutes with either
100 nM of the IP3 inhibitor TMB-8 or with 2.5 mM of the
SERCA pump inhibitor thapsigargin (Figure 1B). When compared
to neurons exposed to only Tat, TMB-8 and thapsigargin failed to
attenuate the loss in ER [Ca
2+] (Figure 1B). In fact, inhibition of
the SERCA pump accentuated the Ca
2+ loss, most likely by
rendering the SERCA pump unable to sequester Ca
2+ back into
the ER (Figure 1B, Ref. 40).
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R) and non-NMDA glutamate receptors (GluR) [43,44]. To rule
out the possibility of these interactions, pharmacological antagonists
of the NMDA receptor recognition site and ion channel were
utilized in combination (Figure 1C). Pretreatment (30 min) with
50 mM of APV and 2 mM of MK-801 failed to attenuate the loss of
ER Ca
2+ (Figure 1C). Likewise, to eliminate the possibility of
AMPA-R activation that might contribute to excess excitatory
neurotransmission, neurons were pretreated with 2 mMo ft h e
AMPA and kainate receptor antagonist CNQX, which alsofailed to
inhibit the loss of ER Ca
2+ (Figure 1C). The addition of the positive
control ionomycin and 10 mM of Ca
2+, increased the absolute
magnitude of CFP:EYFP fluorescence, indicating an increase in ER
[Ca
2+] as expected (Figure 1A).
Unfolded Protein Response pathway proteins are
induced by HIV-1 Tat
A consequence of rapid calcium loss from the ER is the
induction of the UPR, a signaling pathway that can regulate the
volume of the ER to accommodate an increase in unfolded
proteins [45]. Because of the results depicted in Figure 1, we
investigated whether Tat could induce changes in protein species
involved in this response.
In response to 8 nM Tat treatment, a dose that is sub-lethal,
there was a qualitative increase in p-PERK and p-eIF2a between
6–24 hours that persisted for 48 hours as detected by immuno-
blotting (Figure 2A) [27,28,35,43,44], and could be blocked by co-
incubation with antagonist doses of ryanodine (Supplemental
Figure S1). Densitometric analyses confirmed these changes as
statistically significant (Figure 2C), even though the absolute
magnitude of changes was relatively modest when averaged across
6 experimental replicates. Additionally, there was both a total
increase in XBP1 (XBPu+XBPs) protein expression as well as a
25% increase in the active XBPs isoform (Figure 2A, B). The
positive control for induction of the UPR, tunicamycin (1 mg/ml
for 6 h), increased the relative abundance of phosphorylated
species of PERK and eIF2a, as well as XBP1 expression in a
manner similar to that of Tat (data not shown). The data taken
together indicate that exposure to a sub-lethal dose of Tat up-
regulates the UPR at the protein level within 15 minutes and
persists for at least 48 hours.
Figure 1. Endoplasmic reticulum calcium decrease via RyR in
response to HIV-1 Tat. A, Application of 8 nM Tat to transfected
neurons induced the loss of the CFP:EYFP fluorescent signal, indicating
a loss in ER calcium (labeled ‘Tat Only’). Pretreatment with ryanodine for
30 min prior to exposure inhibited this loss in ER calcium. To ensure
that the loss in fluorescence was not due to overexposure, a photo-
bleaching control, Control (no Tat), was performed to demonstrate the
stability of the fluorescent signal. Application of the positive controls,
ionomycin (2 mM) or calcium (10 mM) increased the ER CFP:EYFP
fluorescence (n=5; *, p,0.05; #,p ,0.01). B, Pretreatment with the IP3
inhibitor TMB-8 and the sarco-endoplasmic reticulum Ca
2+-ATPase
inhibitor thapsigargin failed to attenuate the loss of ER calcium when
the transfected cortical neurons were exposed to 8 nM Tat. (n=4; *,
p,0.05 for TMB-8; #,p ,0.05 for thapsigargin). C, Transfected neurons
that were pretreated with either APV/MK-801 or CNQX exhibit the same
relative loss of the ER CFP:EYFP fluorescence, demonstrating the loss of
calcium from the ER and not influx from activation of ionotropic
glutamate receptors (n=4). In Figure 1A, the mean values of CFP:EYFP
fluorescence for ‘Tat Only’ treatment group were plotted, and treated
time points were compared with control time points (before addition of
Tat) for statistical significance. For all other groups (Figure 1A–C), the
values of CFP:EYFP fluorescence were plotted and all time points were
compared with the treatment group ‘Tat Only’ time points for statistical
significance.
doi:10.1371/journal.pone.0003731.g001
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We next investigated whether Tat could also induce morpho-
logic features associated with ER stress at an ultrastructural level in
our in vitro model of cortical neurons. Normal subcellular
morphological features of organelles can be seen in cortical
neurons treated with control vehicle (Figure 3C, D), including the
nucleus, mitochondria and the ER (Figure 3A, C, D). When
cortical neurons were treated with 8 nM Tat for 10 minutes,
several striking morphological changes occurred (Figure 3E, F).
The ER began to increase in abundance and dilate, tubules
became clearly visible, and some of the ribosomes were no longer
apposed to the ER membrane (Figure 3E, F). After 15 minutes of
Tat exposure (Figure 3G, H), the ER underwent labyrinthine
dilatation throughout the cytoplasm of affected cortical neurons
(Figure 3H). Ribosomes in untreated cells were typically
contiguous with the ER membrane (Figure 3A), however after
15 minutes of treatment, Tat also induced ribosomal dissociation,
a classic morphologic feature associated with the UPR (Figure 3B;
Refs. 48,49). These morphologic changes were disproportionately
amplified, but occurred contemporaneously with increases in
protein species associated with the UPR (Figure 2) for as yet
unclear reasons. Ribosomal dissociation occurs in order to stop
new protein synthesis and is another cellular defense mechanism to
relieve stress on the ER [50]. Interestingly, mitochondrial
morphology remained normal during Tat exposure in our in vitro
model (Figure 3C, E, G). We next utilized several pharmacologic
strategies to attenuate the pathologic appearance of the ER after
Tat treatment. Antagonism of the RyR, either with 20 mMR yo r
25 mM dantrolene (Figure 3I and J respectively), completely
abrogated the dilation of the ER and ribosomal dissociation. In
contrast, the IP3 inhibitor TMB-8 and the NMDA-R antagonist
MK-801 failed to attenuate the dilation of the ER, further
confirming our hypothesis that the RyR is the pathologic locus for
Tat-mediated activation of the UPR (Figure 3K and 4L
respectively). This finding was buttressed by the demonstration
of RyR localization to the cisternae of RER using immunogold
labeling (data not shown).
Mitochondrial DYm and Ca
2+ modulated by RyR
activation by Tat
We have previously demonstrated that the mitochondrial
membrane potential [DYm] and [Ca
2+] are directly modulated
by exposure of cortical neurons to Tat [35,39]. In our previous
study, we speculated that loss in mitochondrial Ca
2+ results in the
observed DYm hyperpolarization as measured by rhod123
fluorescence [39]. Several laboratories have demonstrated that
mitochondria express RyR in addition to ER, but the biologic
effects of RyR signaling in mitochondria remain unclear. Because
we had observed similar kinetics of Tat-mediated agonism of RyR
in ER with Ca
2+ loss as well as a decrease in mitochondrial [Ca
2+],
we investigated whether Tat-mediated agonism of mitochondrial
RyR was responsible for hyperpolarization of DYm [51,52].
To examine this question, we transfected cortical neurons with a
CFP:EYFP calmodulin construct with a mitochondrial localization
Figure 2. Endoplasmic Reticulum UPR pathway proteins are
up-regulated by HIV-1 Tat. A, The treatment of cortical neurons with
Tat (8 nM) resulted in the increase in activation of several UPR proteins,
including either phosphorylated species or an increase in the active
protein. There was an increase in p-PERK, eIF2a, XBPu and XBPs levels of
protein in response to Tat exposure. The panels depicting p-PERK, PERK,
p-eIF2a, eIF2a and a-tubulin (AT) are from one experimental replicate
while the panels depicting XBPs, XBPu are from another experiment.
Expression of AT remained invariant after exposure to Tat for all
experimental replicates. B, Using densitometry, the relative expression
of each of the UPR proteins were examined with all bands normalized
to AT to demonstrate that equal amounts of protein were loaded into
each lane. The relative abundance of XBP species are shown in Panel B
and PERK and eIF2a species are shown in Panel C. The phosphorylated
PERK and eIF2a proteins increased to 119% and 117% control
respectively when exposed to Tat for 24 hours (N=7, #,p ,0.01; +,
p,0.005). Both XBPu and XBPs levels demonstrated a similar increase in
concentrations during the described time course (n=6; *, p,0.05).
doi:10.1371/journal.pone.0003731.g002
HIV-1 Tat and Neuronal Stress
PLoS ONE | www.plosone.org 4 November 2008 | Volume 3 | Issue 11 | e3731Figure 3. HIV-1 Tat induces endoplasmic reticulum neuropathologic changes in cortical neurons. A–L, The following symbols are used
throughout the montage: m, mitochondria; n, nucleus; black arrows, ER; white arrows, ribosomes. A, Control neurons displayed classic rough ER
morphology with ribosomes contiguous with the rough ER membrane. B, Cortical neurons treated with 8 nM Tat demonstrated a dilation of ER and a
dissociation of ribosomes. C, An untreated cortical neuron displayed normal morphology. D, A magnified image of the untreated cortical neuron in C.
E, Cortical neuron treated with 8 nM Tat for 15 minutes. F, A magnified image of the treated [8 nM Tat] cortical neuron. G, Cortical neuron treated
with [8 nM] Tat for 15 minutes displayed dilated ER. H, Magnified image of treated neuron in G. The dilated ER at this level of magnification was
highly prominent. I, Cortical neurons pretreated with an antagonist concentration [20 mM] of ryanodine for 30 min before [8 nM] of Tat treatment
displayed none of the pathology demonstrated in previous images. J, Cortical neurons pretreated with the RyR antagonist [25 mM] dantrolene for
30 min before [8 nM] of Tat treatment had similar morphologies to those that received [20 mM] ryanodine pretreatment. K, Cortical neurons
pretreated with the IP3 inhibitor [100 mM] TMB-8 for 1 hour before Tat [8 nM] treatment failed to attenuate the morphological pathology induced by
Tat. L, Cortical neurons pretreated for 30 minutes with 2 mM MK-801 also failed to attenuate the pathology elicited by treatment of Tat [8 nM].
doi:10.1371/journal.pone.0003731.g003
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2+]mito)
[39,53]. After treatment of cortical neurons with 8 nM Tat, we
observed a loss in CFP:EYFP fluorescence, confirming a decrease in
[Ca
2+]mito (Figure 4A). When we pre-treated the neurons with an
antagonist concentration [20 mM] of ryanodine for 30 min, the loss
of [Ca
2+]mito was significantly attenuated (Figure 4A). Unfortunate-
ly, imaging of dantrolene-treated cultures in this paradigm was
unsuccessful because of its autofluorescent properties at both the
CFP and EYFP wavelengths, which precluded our ability to
corroborate whether it also antagonized RyR in this paradigm. The
addition of either a positive control, ionomycin or calcium [10 mM]
increased the absolute magnitude of CFP:EYPF fluorescence,
demonstrating the specificity of mitochondrial RyR effects on
[Ca
2+]mito stores (Figure 4A).
To correlate the loss of [Ca
2+]mito with mitochondrial
hyperpolarization, we used the lipophilic dye rhod123 in this
experimental paradigm. Because rhod123 is cationic, it selectively
accumulates in the mitochondria matrix proportional to the
electronegativity of the mitochondrial membrane potential and
thus provides a quantitative measure of DYm. Since rhod123
exhibits auto-quenching properties at high concentrations, a
decrease in the fluorescence indicates a more hyperpolarized
DYm. Addition of 8 nM Tat to cortical neurons resulted in a loss
of rhod123 fluorescent signal, indicating mitochondrial hyperpo-
larization (Figure 4B). When Tat-challenged neurons were pre-
treated with 20 mM Ry for 30 min in order to block the observed
[Ca
2+]mito loss, we observed a significant rise in the rhod123
fluorescence, indicating mitochondrial depolarization. Pretreat-
ment (30 min) with the RyR antagonist, dantrolene, was also
tested to further confirm specificity of the RyR for mediating these
pathologic effects. A rise in rhod123 signal was also observed with
co-incubation of Tat with dantrolene, indicating mitochondrial
depolarization (Figure 4B). In aggregate, these data suggest that
blocking the RyR inhibits [Ca
2+]mito loss, and that it is this loss in
[Ca
2+]mito that is responsible for the observed mitochondrial
hyperpolarization when neurons are exposed to Tat.
Localization of RyR on inner mitochondrial membrane
The observation that pharmacological antagonism of the RyR
in neurons exposed to Tat modulated both mitochondrial
membrane potential and Ca
2+ stores lead us to ask whether we
could observe RyR that localize to the mitochondria. To further
validate the physiologic significance of this, we used silver-
enhanced immunogold immunohistochemistry of thin sections of
murine brain tissue to demonstrate that there are RyR present in
neuronal mitochondria visualized as distinct punctae that co-
localized exclusively with the inner mitochondrial membrane
(IMM) (Figure 5A). To rule out non-specific antibody staining, we
used a control IgG antibody that demonstrates no significant
background staining (Figure 5B).
Pathologic alterations in ER and mitochondrial
morphology in vivo
To determine whether abnormalities in mitochondria and RER
morphology also occurred in an in vivo model of Tat-induced
neurodegeneration, we injected Tat into the frontal cortex of
young adult (3 month old) wild type C57Bl/6J mice, and sacrificed
them 4 weeks later for ultrastructural analysis. Figure 6 demon-
strates that a single injection of Tat had profound, enduring
consequences on both RER and mitochondria, in contrast to our
in vitro experiments where only RER showed dramatic changes in
architecture (Figure 3H). In contrast to mice that received vehicle
control injections, Tat-injected mice had dilated ER, with
irregularly shaped cisternae and in some cases, vacuolization.
Figure 4. HIV-1 Tat mediated mitochondrial calcium loss and
hyperpolarization is mediated through the ryanodine recep-
tor. A, Treatment with 8 nM Tat of cortical neuron in only media
resulted in a 10% loss in CFP:EYFP calmodulin fluorescence. The
pretreatment with ryanodine for 30 minutes prior to exposure to 8 nM
Tat inhibited the loss of fluorescent signal (n=4; *, p,0.05; #,p ,0.01).
B, Treatment with 8 nM Tat of cortical neuron resulted in the rapid loss
in rhod123 fluorescence, indicating mitochondrial hyperpolarization.
Incubation with either an inhibitory concentration of ryanodine or the
RyR inhibitor dantrolene for 30 minutes before Tat treatment [8 nM]
resulted in the rapid loss in rhod123 signal, indicating mitochondrial
d e p o l a r i z a t i o n( n = 5 ;* ,p ,0.05; #,p ,0.001). Addition of the
mitochondria specific protonophore, carbonyl cyanide-4(trifluoro-
methoxy)phenylhydrazone (FCCP; [10 mM]), initiated a rapid depolar-
ization of the mitochondria and served as a positive control. The values
of CFP:EYFP and rhod123 fluorescence were plotted and all time points
were compared with the treatment group ‘Tat Only’ time points for
statistical significance.
doi:10.1371/journal.pone.0003731.g004
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cristae.
Our previous studies [13,35,39] have modeled synaptic and
mitochondrial pathology that may occur during HIV-1 infection
of the CNS. Surprisingly, there has been a paucity of studies
investigating ultrastructural changes that occur during HIV-1
induced neurodegeneration, with the exception of a study by Weis
et al. [18] that reported vacuolization and thinning of the basal
lamina, with an increase in the volume, but not number of cortical
vessels in brain tissue from patients with AIDS. To gain a better
understanding of how neuronal mitochondria and other subcel-
lular organelles such as ER are affected during HIV-1 neurode-
generation, we performed an ultrastructural survey of frontal
cortex from brain tissue of three patients with HIVE and dementia
and three patients with HIV-1, but no evidence of brain
pathology. Figure 7 demonstrates normal rough ER (RER)
cisternae and mitochondria in frontal cortex from an age-matched
patient with HIV-1 and no neurologic disease, in contrast to
greatly dilated RER (upper panels) with irregularly shaped
cisternae and scattered deposits of electron dense material present
in frontal cortex of patients with HIVE and dementia. Lower
panels depict very abnormal mitochondria with irregular cristae
and electron dense material, surrounded by dilated ER cisternae.
These findings of pathologic changes in organellar ultrastructure
may reflect the chronic effects of HIV-1 infection on normal
mitochondrial and RER function in cortical neurons in contrast to
Figure 5. RyR are located in the inner mitochondrial membrane. A, Neuronal RyR expression (short arrows) is contiguous with the inner
mitochondrial membranes (IMM) from rodent brain as visualized by silver-enhanced immunogold cytochemistry. B, Control sections were incubated
with gold-labeled secondary antibodies in the absence of primary antibody and demonstrate no appreciable, non-specific staining.
doi:10.1371/journal.pone.0003731.g005
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patients with HIVE and three patients with HIV-1 but no
discernible brain pathology, we are unable to discern whether
HAART is a potential confound because HAART use is present to
some degree in both groups.
Discussion
We have previously shown that HIV-1 Tat has deleterious
effects on neuronal calcium homeostasis that initiates a cellular
stress response by hyperpolarizing cortical mitochondria [39]. In
this work, we provide insights into possible mechanisms for ER
and mitochondrial abnormalities observed in the frontal cortices of
mice that have received stereotactic injections of Tat and patients
with HIVE and dementia. Here we demonstrate that sub-lethal
HIV-1 Tat exposure activates the UPR with unique pathologic
changes in ER morphology specific to cortical neurons vs. glia
(data not shown). In addition to the observed ER effects, our data
further suggest that signaling through the RyR plays an integral
role in the regulation of mitochondrial homeostasis [39]. The
implications of these findings are discussed below.
The Unfolded Protein Response
The UPR response has been postulated to be a common
mechanism for a variety of neurodegenerative disorders due to the
observation that unfolded or misfolded protein accumulation may
increase during the pathogenesis of these disease states [30]. For
example, plaques in Alzheimer’s disease (AD) involve the
accumulation of b-amyloid and similarly, aggregated a-synuclein
is a hallmark of Parkinson’s disease (PD), evidence that supports a
pivotal role for the UPR in cellular stress [54,55]. Viral infections
have also been implicated in UPR induction, including borna
disease virus, flaviviruses (yellow fever, West Nile, etc.) and
hepatitis B virus [34,56,57]. In this study, we investigated whether
Tat could induce the UPR as a key pathogenetic mechanism for
neuronal dysfunction that occurs during HIV-1 associated
neurologic disease.
The ER is a specialized intracellular organelle whose protein
folding capacity is dependent on maintaining a relatively oxidized
environment and high calcium concentrations required for
chaperone molecules [45]. The ER is responsible for the storage
of Ca
2+ and has the ability to induce rapid efflux of Ca
2+ in
response to a variety of cellular signals, including inositol 1,4,5-
triphosphate (IP3) receptors and ryanodine receptors (RyR) [40].
HIV-1 Tat is know to modulate intracellular calcium concentra-
tions through several different mechanisms, but these measure-
ments were based on use of calcium sensitive dyes that are not
localized to specific intracellular compartments [27]. Using an ER-
targeted calmodulin EYFP construct, we were able to ascertain the
kinetics of ER calcium modulation by Tat.
Figure 6. HIV-1 Tat induces endoplasmic reticulum and mitochondrial changes in frontal cortex of mice. Wild type C57Bl/6J received
stereotactic injections of vehicle control or HIV-1 Tat (50 mmols) into frontal cortex, followed by sacrifice 4 weeks later. Frontal cortex was processed
for electron microscopy. The upper and lower panels on the left depict normal morphology of RER and mitochondria, respectively. The upper panels
on the right demonstrate mild ER dilatation with occasional vacuolization. The lower panels on the right demonstrate abnormally enlarged
mitochondria with increased cristae.
doi:10.1371/journal.pone.0003731.g006
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2+]i n
cortical neuronal ER (Figure 1A), an effect abolished by co-
incubation with an antagonist concentration of ryanodine,
indicating that there is an interaction of Tat with the RyR but
not IP3 receptors (Figure 1B). Tat has several other targets,
including ionotropic glutamate receptors [43,44]. Thus antago-
nism of either NMDA or non-NMDA receptor subtypes after
exposure to a sub-lethal dose of Tat failed to change ER [Ca
2+]
(Figure 1C). The data suggests one of two possible mechanisms:
either Tat is activating the RyR through a direct interaction, or it
is sensitizing the receptor to cytosolic calcium; a similar effect can
be observed with caffeine application [40].
We next investigated what sort of response associated with the
UPR may occur in our experimental paradigm. As unprocessed
proteins accumulate in the ER a repertoire of cellular defense
pathways are activated to restore proper function. An early event
in UPR induction is the phosphorylation of one or more,
transmembrane proteins that relay cytosolic information to the
ER [30]. Activation of the transmembrane kinase IRE1 pathway
occurs after it dimerizes and autophosphorylates, activating an
RNase domain [46,47]. Another parallel pathway that is
metabolically active during the UPR involves PERK phosphor-
ylation (p-PERK). p-PERK perpetuates the UPR by phosphory-
lating the eukaryotic initiation factor eIF2a (p-eIF2a). Because the
immediate consequence of increased expression of p-eIF2a is a
whole scale shutdown of protein translation in the ER, we
investigated the phosphorylation of these protein species.
We demonstrate that IREa and PERK phosphorylation
occurred in our paradigm because of the increase in abundance
for p-PERK and phosphorylated eIF2a (Figure 2A, B) while
simultaneously, p-IREa up-regulated the gene XBP1 that splices a
26nt [32] from the mRNA to produce the transcription factor
product, XBPs (Figure 2A, B). Interestingly, the Tat induced
upregulation of p-PERK, XBPu, and XBP1s was significantly
attenuated (to 90% of Tat expression) by the pretreatment of
ryanodine [20 mM] for 30 min before treatment at the 1-hour
time point (Supplemental Figure S1). Similarly, the increase in p-
eIF2a expression was attenuated at the 6-hour time point
(Supplemental Figure S1). Up-regulation of XBPs, a crucial
transcription factor, can increase the capacity of the ER to fold
proteins during the UPR that could be attributed to the activation
of this portion of UPR pathways [29,46]. The discrepancy
between the small magnitude of the protein changes relative to
the striking ultrastructural changes observed after 8 nM Tat
treatment in cortical neurons (Figure 3E–H) suggests that there
may be some type of amplification process via post-translational
modification of cytoskeletal proteins that control shape of ER
cisternae. Additionally, the lack of changes in mitochondrial
morphology (i.e. cristae) during acute exposure to Tat in our in
vitro model, suggests that this phenomenon is dependent on
pathways that subserve an inflammatory response only present in
an in vivo milieu. While the ability of antagonist doses of ryanodine
to inhibit Tat-induced phosphorylation of UPR gene products
confirms that the rapid decrease in ER [Ca
2+] is the initiating step
for ER dysfunction, further studies beyond the scope of this report
are required to delineate the mechanism(s) responsible for these
morphologic changes and resolve the kinetic differences between
our in vitro and in vivo models.
Figure 7. Ultrastructure of frontal cortex from patients with HIVE and dementia. Brain tissue from HIV-1 patients without the
neuropathologic hallmarks of HIVE and patients with HIVE and pre-mortem diagnosis of dementia was prepared for electron microscopic analyses as
described in Methods. The panels in the montage on the left depict normal neuronal RER and mitochondrial morphology for patients with HIV-1 but
no evidence of brain pathology. In contrast, the panels on the upper right depict grossly dilated neuronal RER with scattered deposit of electron
dense material and the panels in the lower right depict neuronal mitochondria with abnormal cristae and deposits of electron dense material
adjacent to dilated ER cisternae.
doi:10.1371/journal.pone.0003731.g007
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the morphological changes that are apparent in the EM
photomicrographs (Figure 3). In untreated neurons, the ER is
barely visible, as rows of ribosomes that line the ER membrane
(Figure 4A, C, D). This normal ER morphology is disrupted when
Tat induces the UPR and as a result, the ER becomes dilated, with
detached ribosomes no longer in apposition to the ER membrane
(Figure 3B, G, H). There is also a structural abnormality that we
were unable to identify and appears to be a filament running
‘‘through’’ the ER (Figure 3B).
Downstream Consequences of UPR Induction
The observed ER dysfunction and induction of the UPR
pathway in cortical neurons may have additional ramifications.
HIV infected macrophages or restrictively infected astrocytes
release TNFa into the extracellular milieu and is a key
inflammatory mediator in models for the observed chronic
inflammation in HIV Associated Neurologic Disease (HAND)
[2,58–60]. Interestingly, induction of the UPR intersects with the
TNFa signaling pathway because the phosphorylated species of
the transmembrane protein IREa can interact directly with the
tumor necrosis factor receptor-associated factor 2 (TRAF2), which
is also an initiation step for induction of the UPR [61,62].
Mitochondrial hyperpolarization and the RyR
Perhaps our most intriguing data demonstrates the presence of a
functionally active RyR proximate to or physically associated with
mitochondria. We previously examined whether loss of mitochon-
drial calcium was responsible for mitochondrial hyperpolarization
[39], and demonstrated there is a coordinated loss of mitochondrial
calcium with membrane hyperpolarization (Figure 5 in Ref. 39).
Based on this, we pre-treated cortical neurons with an antagonist
concentrationof ryanodineand then measured [Ca
2+]mito and DYm
in response to Tat (Figure 4). Ryanodine attenuated Tat’s effects on
both [Ca
2+]mito and DYm, suggesting that there is a functional RyR
on mitochondria that is responsible for Tat’s ability to reduce
[Ca
2+]mito and hyperpolarize the mitochondrial membrane, a novel
finding that has not been previously demonstrated in other studies
investigating expression of RyR in mitochondrial membranes and
its implications inneurodegenerative diseases [51,52]. Inaddition to
the pharmacological evidence for a functional RyR on mitochon-
dria, we demonstrate the physical presence of mitochondrial RyR
localized to the IMM, using silver-enhanced immunogold electron
microscopy (Figure 5). Unlike previous studies, we performed these
EM studies on intact neurons in murine brain rather than on
isolated mitochondria, which eliminates the confounding factor of
ER contamination after subcellular fractionation [51,52]. Because
the outer mitochondrial membrane is very porous in contrast to the
IMM, it is highly likely that this population of RyR represents a new
therapeutic target for processes that alter mitochondrial calcium
homeostasis.
In summary, our data implicates multiple roles for a sub-lethal
dose of HIV-1 Tat in eliciting a general stress response in cortical
neurons that involves activation of the RyR with reversible ER
dysfunction, the UPR and mitochondrial hyperpolarization. These
results raise the interesting and novel possibility that the RyR may
be a crucial target for neuroprotection in HIV-associated
neurologic disease.
Materials and Methods
Reagents
The recombinant HIV-1 Tat1-72 was generously provided by
the laboratories of Dr. Avindra Nath and Phil Ray [43]. The
D1ER construct was a generous gift from Dr. Roger Y. Tsien
(Dept. of Pharmacology, UCSD, San Diego, CA) and the YC3.1
construct [53,63] was a generous gift from laboratory of Dr.
Nicolas Demaurex (Dept. of Physiology, University of Geneva,
Switzerland) and was originally developed by Dr. Roger Y. Tsien
(Dept. of Pharmacology, UCSD, San Diego, CA). The dyes
rhodamine 123, and ER-Tracker Red were purchased from
Molecular Probes (Invitrogen, Carlsbad, CA). B27 supplement
(with and without anti-oxidants), Neurobasal media and PCR
primers were purchased from Invitrogen. Ryanodine was
purchased from Calbiochem (EMD Biosciences, La Jolla, CA)
and dantrolene was purchased from Tocris (Ellisville, MO).
Antibodies for western blots were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). All other chemicals and reagents
were purchased from Sigma (St. Louis, MO).
Primary Neuronal Cell Culture
Primary neuronal cortical cultures were harvested and prepared
from embryonic day 18 Sprague-Dawley rat pups as previously
described by Brewer [64] and modified in Norman et al. [39]. In
brief, the cortices were isolated from a litter of E18 rats and the
meninges and extraneous tissue removed. The cortices were
incubated in 2mL of Ca
2+/Mg
2+ free Hank’s balanced salt
solution (HBSS with 10 mM HEPES, pH 7.3) with gentamicin
(50 mg/mL) and 0.25% trypsin for 15 min at 37uC. The cells were
centrifuged at 1000 rpm for 5 min, washed twice with HBSS (with
Ca
2+/Mg
2+), then dissociated in Neurobasal media supplemented
with glutamate, gentamicin and B27 supplement (Life Technol-
ogies, Gaitherburg, MD) by 10 passages through a 0.9 mm bore
pipette tip. Dissociated cells were counted using the trypan blue
viability assay and were plated on poly-D-lysine coated cell culture
plastic and incubated in a humidified atmosphere of 5% CO2/
95% air at 37uC. The supplemented Neurobasal media is modified
for an anti-oxidant free culture as described by Perry et al. [35],
and inhibits the growth of glial cell populations. The resulting
cultures are 98% pure neuronal cultures [64]. Cultures were used
for experiments at days in vitro (DIV) 11-14 unless otherwise noted.
Animal studies
Male wild type C57Bl/6J mice, three months old, received
stereotactic injections (AP 21.5 mm, lateral 1 mm, depth 2 mm)
of 50 mmols of Tat1-72 or control vehicle in 2 ml, followed by
sacrifice and intracardiac perfusion with paraformaldehyde 4
weeks later. All animal studies were conducted under the NIH
guidelines of the committee for animal resources of UCSD.
Electron Microscopy
In vitro studies. Electron microscopy was performed using
the cultured cell pop-off method described in de Mesy Jensen, et
al. [65]. Briefly, cells were fixed onto chamber slides using 0.1 M
phosphate buffered 2.5% glutaraldehyde, pH 7.4 overnight. The
slides were rinsed in two changes of phosphate buffer and post-fix
using phosphate buffered 1.0% osmium tetroxide for 30 minutes.
Cells were dehydrated by passing slides through a graded series of
ethanol to 100% (63), transitioning into Spurr epoxy resin, then
100% resin overnight. Embedment of cells was accomplished after
filling size 3 Beam capsules with fresh resin and inverting for
placement upon glass slide surface. The slides/capsules were
polymerized at 70uC overnight. The next day, the surface tension
between capsules and slide surfaces was broken by dipping slides
into liquid nitrogen several times until capsules disengaged.
Inverted capsules were examined under the light microscope
and an area to be thin-sectioned was chosen. The capsules were
trimmed of excess epoxy and thin sectioned onto copper grids.
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citrate. The cells were examined with a Hitachi 7100 transmission
electron microscope with digital image capture using a MegaView
III camera (Soft-Imaging System, Lakewood, Colorado).
Ex vivo studies. Frontal cortices from three separate cases
with the neuropathologic hallmarks of HIV encephalitis (HIVE)
and a pre-mortem history of HIV-1 associated dementia (HAD) or
age-matched HIV-1 patients without discernible evidence of
HIVE or HAD were used in these studies. The pre-mortem
history for these patients revealed that 2/3 cases with HIVE had
not received HAART for .5 months prior to death, while the
other case had HAART 20 days prior to death. 2/3 of the cases
without evidence of HIVE were on HAART until 1 week prior to
death and the other case discontinued HAART 2.5 months prior
to demise. Brain tissue regions from these patients were prepared
for electron microscopic studies by vibratoming 40 mM sections
from paraformaldehyde-fixed tissue blocks, followed by
embedment in Epon-Araldite and sectioning with the Reichert
Ultracut-E ultramicrotome (Leica, Vienna, Austria), placement on
200-mesh copper grids, and staining in saturated ethanol/uranyl
acetate and bismuth nitrate, as previously described [66]. From
each case, approximately 10 sections (90-nm-thick) were analyzed
with the Zeiss EM10 Electron Microscope at 5, 10, 20, and 50 K
magnifications in order to evaluate the ultrastructural
characteristics of subcellular organelles in neurons. For animal
studies, mice were sacrificed and paraformaldehyde-fixed tissue
blocks were cut by vibratome at 40 mM thickness, followed by
post-fixation processing and analysis as described above.
Immunogold Cytochemistry
Briefly, Vibratome sections were fixed in 0.25% glutaraldehyde
and 3% paraformaldehyde in 0.1 M cacodylate buffer (pH 7.4),
and then pre-embedded with 50%Durcupan epoxy resin, and
50% ethanol (anhydrous) for 30 min, and then embedded in
Durcupan mix epoxy resin with polymerization under vacuum at
60 C for 48 hrs. After the resin was polymerized, tissues were
mounted into plastic cylinders, sectioned with an ultra microtome
(Reichert Ultracut E) at 60 nm thickness and collected on nickel
grids for immunogold labeling. The grids were treated for antigen
retrieval (sodium periodate saturated in water) for 1 min, washed
in water, blocked with 3% BSA in TBS for 30 min, and then
incubated with the anti-RyR (Sigma, Clone 34C; 1:100) overnight.
The following day, the grids were washed in TBS, blocked with
3% BSA, and incubated with the secondary antibody, IgG-
antimouse/10 nm gold particles (AURION Immunogold re-
agents) for 2 hrs. at room temp. The grids were washed in TBS
and distilled water. To enhance RyR labeling, we used a silver
mixture (AURION R-gent SE-EM) for 25 min, then washed
extensively with distilled water, and contrasted as follows: The
immunostained grids were post-stained using saturated Uranyl
Acetate solution in 50% Ethanol, for 20 min. at room tempera-
ture, then washed in distilled water, and placed in bismuth nitrate
solution for 10 min followed by a final wash in distilled water. In
control experiments, grids were incubated with gold-labeled
secondary antibodies in the absence of primary antibody. The
immunolabeled grids were analyzed with a Zeiss EM10 electron
microscope; neurons were identified morphologically and the
electron micrographs were obtained at a magnification of 35,000.
Image Capture and Image Analysis
In order to image and measure physiological changes in real
time, we employed fluorescent dyes. The protocol for fluorophore
was utilization was previously described (MY). Briefly, samples
were placed on a DC60 warming stage (Linkam Sci. Instruments,
Surrey, UK) and maintained at 37uC for the duration of the
experiment. A single field was monitored during the course of the
experiment and images were taken using an Olympus IX-70
microscope with 406 objective and an Apogee KX32ME CCD
camera. The resulting images were analyzed using Scanalytics
IPLab software. Quantification of the neuronal fluorescent
intensity was determined by the total sum of the recorded pixel
values within the specified region of interest (ROI), for each image
series captured.
Internal Endoplasmic Reticulum and Mitochondria Ca
2+
Measurements
Endoplasmic reticulum and mitochondrial Ca
2+ measurements
were accomplished through the use of either an ER targeted or a
mitochondrial targeted YFP-calmodulin construct. Briefly, cortical
neurons were transfected using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA) using 2 mL Lipofectamine to 1 mg DNA for each
culture plate. Cortical neurons were incubated for 24 hours at 5%
CO2/95% air at 37uC for before the Lipofectamine was removed
and returned to the incubator for 4 days. Transfected cultures
were placed in Leibovitz’s L-15 medium (Gibco) and incubated at
37uC in room air for 25 minutes before imaging. The appropriate
experimental treatment was added directly to the media and the
fluorescence resonance energy transfer (FRET, i.e. whereby the
donor fluorophore CFP excites the acceptor fluorophore EYFP via
nonradiative dipole-dipole interaction) measured from cyan
fluorescent protein (CFP) at 425/480 (ex/em) (custom filter;
Chroma Technology) to EYFP fluorescence at 425/540 (ex/em)
(Lucifer Yellow filter; Chroma Technology) [34,41]. Data are
expressed as the ratio between the emissions of CFP to EYFP at
480/540 nm.
Assessing mitochondrial DYm
Mitochondrial DYm was determined, as described previously
[24,39]. Briefly, 10 mM rhod123 was incubated with cortical
neuronal cultures under normal incubation conditions for 30 min.
The rhod123-containing medium was removed, and the cultures
were placed in CO2-insensitive, pH-stable Leibovitz’s L-15
medium (Invitrogen Life Technologies) containing 10 mM
rhod123 and incubated at 37uC in room air for 15 min to allow
for the rhod123 fluorescent signal to reach a steady state. Culture
treatment was applied directly to the bath medium. Samples were
imaged using a Texas Red filter (Chroma Technology) at 560/645
(ex/em). The high concentration of rhod123 causes the fluor-
ophore to quench, which inversely correlates with the DYm.
Immunoblot analysis
Primary cortical neurons (1610
6) were rinsed three times with
ice-cold phosphate buffered saline (PBS) and lysed in lysis buffer
(50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 5 mM EDTA, 1 mM
dithiothreitol, 1% Nonidet P-40, 0.1 mM sodium vanadate,
20 mM b-glycerophosphate, and 20 mM p-nitrophenylphosphate)
in the presence of 1 mM phenylmethylsulphonylfluoride (PMSF)
and a protease inhibitor cocktail (Sigma, St. Louis, MO). Samples
were incubated on ice for 30 min, homogenized, and centrifuged
for 5 min at 13,000g at 4uC. The pellet was discarded and the
supernatant total protein was quantified using the Lowry protocol
(Dc Protein Assay, Bio Rad, Hercules, CA). An equal amount of
protein (25 mg) was used for each sample and they were separated
by 12% SDS-PAGE. The protein was transferred onto a
polyvinylidene difluoride (PVDF) membrane. The resulting
membrane was blocked with a 5% milk solution (0.3% Tween-
PBS) for one hour at room temperature. The following antibodies
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PERK (1:1000, anti-rabbit), eIF-2a (1:1000, anti-goat), p-eIF-2a
(1:500, anti-goat), and XBP1 (1:500, anti-rabbit). In addition, each
blot was probed with a-tubulin (1:2000, anti-mouse) as a loading
control, and densitometric data were normalized to a-tubulin. The
resulting bands were detected using chemiluminescence (ECL
Western Blotting Detection, Amersham, Buckinghamshire, UK).
Western blots were digitally photographed using an illuminator
with a digital camera (Northern Light, Canada) and densitometry
was performed using Scion Image.
Data and statistical analysis
The raw data were analyzed from 3–5 independent experiments
and expressed as the mean6SEM. Where applicable, the
percentage of control and percentage of control SEM for each
treatment condition were calculated by dividing the raw means
and raw SEM’s by the control condition raw mean. A Student’s t
test using a two-tailed distribution and unequal variance was used
to compare data. A probability of p,0.05 was considered
statistically significant.
Supporting Information
Figure S1 Treatment with Ryanodine decreases acute UPR
pathway induction. A, Cortical neurons were either pretreated
with an antagonist concentration of ryanodine [20 mM] for
30 min before Tat [8 nM] exposure or were exposed to Tat
alone and UPR protein levels were measured via western blotting.
The bands shown are representative of all western blots quantified.
B, Densitometry was performed as described in the Methods
section, but bands were normalized to expression of beta tubulin
(BT), which was invariant throughout the time course of the
experiment. Ryanodine bands were expressed as the percent
optical density (O.D.) of the Tat only-treated bands. (n=3,
*=p,0.05 for XBPu, XBPs and p-PERK @1 hr and for XBPu,
XBPs and p-eIF2a @6 hr).
Found at: doi:10.1371/journal.pone.0003731.s001 (0.94 MB
DOC)
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